201. Evaluation of Bcl-2 family gene expression in hippocampus of 3, 4-methylenedioxymethamphetamine treated rats
- Author
-
Asl, S. S., Farhadi, M. H., Moosavizadeh, K., Saraei, A. S. K., Soleimani, M., Jamei, S. B., Mohammad Taghi Joghataei, Samzadeh-Kermani, A., Hashemi-Nasl, H., and Mehdizadeh, M.
- Subjects
lcsh:R ,3, 4-methylendioxymethamphetamine (MDMA) ,lcsh:Medicine ,Apoptosis ,Biochemistry ,4-methylendioxymethamphetamine (MDMA) ,Cellular and Molecular Biology ,Genetic ,Bax ,mental disorders ,lcsh:Q ,Bcl-2 ,lcsh:Science ,psychological phenomena and processes ,Research Article - Abstract
Objective: 3,4-methylenedioxymethamphetamine (MDMA) is an illicit, recreational drug that causes cellular death and neurotoxicity. This study evaluates the effects of different doses of MDMA on the expression of apoptosis–related proteins and genes in the hippocampus of adult rats. Materials and Methods: In this expremental study,a total of 20 male Sprague Dawley rats (200-250 g ) were treated with MDMA (0, 5, 10, 20 mg/kg i.p. twice daily) for 7 days. Seven days after the last administration of MDMA, the rats were killed. Bax and Bcl-2 genes in addition to protein expressions were detected by western blot and reverse transcriptionpolymerase chain reaction (RT-PCR).Results were analyzed using one-way ANOVA and p≤0.05 was considered statistically significant. Results: Our results showed that MDMA caused dose dependent up-regulation of Bax and down-regulation of Bcl-2 in the hippocampus. There was a significant alteration in bcl-2 and bax genes density. Conclusion: Changes in apoptosis-related proteins and respective genes relating to Bax and Bcl-2 might be involved in the molecular mechanism of MDMA-induced apoptosis.